Polysulfone-Based Membranes Modified with Ionic Liquids and Silica for Potential Fuel Cell Applications.

The urgent need for sustainable, low-emission energy solutions has positioned proton exchange membrane fuel cells (PEMFCs) as a promising technology in clean energy conversion. Polysulfone (PSF) membranes with incorporated ionic liquid (IL) and hydrophobic polydimethylsiloxane-functionalized silica (SiO-PDMS) were developed and characterized for their potential application in PEMFCs. Using a phase inversion method, membranes with various combinations of PSFs, SiO-PDMS, and 1-butyl-3-methylimidazolium triflate (BMI.

A Biobased Epoxy Vitrimer with Dual Relaxation Mechanism: A Promising Material for Renewable, Reusable, and Recyclable Adhesives and Composites.

This study presents the synthesis of a novel biobased epoxy monomer derived from vanillin and cystamine, incorporating imine and disulfide exchangeable groups within its structure. A series of epoxy-based vitrimers with two simultaneous exchange relaxation processes have been produced using this monomer. These exchange mechanisms operate without the need for any catalyst.

Editorial on Special Issue "Marine Gels".

The ocean is a complex polymer solution [...

Early Recovery of Myeloid-Derived Suppressor Cells After Allogeneic Hematopoietic Transplant: Comparison of Post-Transplantation Cyclophosphamide to Standard Graft-Versus-Host Disease Prophylaxis.

Allogeneic hematopoietic cell transplantation (alloHCT) using haploidentical donors (haploHCT) with post-transplantation cyclophosphamide (PTCy) for augmented graft-versus-host disease (GVHD) prophylaxis has emerged as a robust platform to expand donor options with acceptable levels of GVHD and graft failure. The mechanism by which PTCy mitigates GVHD risk is partly explained by preferential cytotoxicity based on aldehyde dehydrogenase levels and up-regulation of regulatory T cells, but is incompletely understood. Myeloid-derived suppressor cells are important mediators of T-cell function and are up-regulated by cyclophosphamide exposure.